HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thierry Brue Selected Research

Somatostatin (Somatotropin Release-Inhibiting Factor)

6/2021Characterization of the ability of a, second-generation SST-DA chimeric molecule, TBR-065, to suppress GH secretion from human GH-secreting adenoma cells.
1/2021Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study.
1/2021Correction to: Pegvisomant in combination or pegvisomant alone after failure of somatostatin analogs in acromegaly patients: an observational French ACROSTUDY cohort study.
6/2017Anti-proliferative and anti-secretory effects of everolimus on human pancreatic neuroendocrine tumors primary cultures: is there any benefit from combination with somatostatin analogs?
11/2016T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegaly.
12/2014Ghrelin receptor (GHS-R1a) and its constitutive activity in somatotroph adenomas: a new co-targeting therapy using GHS-R1a inverse agonists and somatostatin analogs.
11/2014Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial.
9/2014Pituitary apoplexy after somatostatin analogue administration: coincidental or causative?
1/2012Inactivation of transcription factor pit-1 to target tumoral somatolactotroph cells.
11/2010Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thierry Brue Research Topics

Disease

32Acromegaly
12/2023 - 08/2005
31Neoplasms (Cancer)
05/2023 - 05/2007
24Pituitary Neoplasms (Pituitary Adenoma)
12/2023 - 07/2003
14Pituitary ACTH Hypersecretion
01/2023 - 12/2004
13Hypopituitarism (Sheehan's Syndrome)
12/2023 - 03/2004
12Cushing Syndrome
01/2024 - 01/2010
12Prolactinoma (Prolactinomas)
01/2023 - 05/2007
10Adenoma (Adenomas)
06/2018 - 02/2002
8Combined Pituitary Hormone Deficiency
11/2021 - 08/2005
7Adrenal Insufficiency (Adrenal Gland Hypofunction)
01/2023 - 11/2004
6Growth Hormone-Secreting Pituitary Adenoma
11/2021 - 09/2007
5Hypothyroidism
01/2023 - 08/2005
5Hypertension (High Blood Pressure)
06/2018 - 10/2010
4Hypokalemia
06/2018 - 01/2010
3Obesity
03/2024 - 06/2012
3Hypophysitis
05/2023 - 02/2015
3Hypoglycemia (Reactive Hypoglycemia)
01/2023 - 01/2011
3Common Variable Immunodeficiency
01/2023 - 01/2012
3Hyperplasia
12/2021 - 02/2016
3Cardiovascular Diseases (Cardiovascular Disease)
09/2021 - 06/2012
3Primitive Neuroectodermal Tumors (PNET)
02/2020 - 10/2014
3Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2020 - 10/2014
3Perinatal Death
01/2011 - 11/2004
3ACTH-Secreting Pituitary Adenoma
09/2010 - 07/2003
3Carcinogenesis
09/2010 - 05/2007
2Diabetes Insipidus
03/2024 - 02/2022
2Vision Disorders (Hemeralopia)
12/2023 - 04/2020
2Headache (Headaches)
12/2023 - 09/2019
2Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2021 - 06/2012
2Type 2 Diabetes Mellitus (MODY)
09/2021 - 01/2020
2Necrosis
01/2015 - 01/2009
2Rare Diseases (Rare Disease)
06/2012 - 04/2012
2Infections
01/2012 - 12/2008
1Weight Loss (Weight Reduction)
03/2024
1Craniopharyngioma (Craniopharyngiomas)
03/2024
1Colonic Polyps
12/2023
1Carpal Tunnel Syndrome
12/2023
1Erectile Dysfunction
12/2023
1Fatigue
12/2023
1Arthralgia (Joint Pain)
12/2023
1Thyroid Nodule (Nodule, Thyroid)
12/2023

Drug/Important Bio-Agent (IBA)

20ProlactinIBA
03/2024 - 07/2003
18Adrenocorticotropic Hormone (ACTH)FDA Link
03/2024 - 03/2005
17Hormones (Hormone)IBA
12/2023 - 03/2004
16Growth Hormone (Somatotropin)IBA
03/2024 - 12/2008
13Hydrocortisone (Cortisol)FDA LinkGeneric
01/2023 - 09/2009
13pegvisomantFDA LinkGeneric
06/2022 - 01/2009
11Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2021 - 12/2008
10Dopamine Agonists (Dopamine Agonist)IBA
08/2023 - 04/2010
10Transcription Factors (Transcription Factor)IBA
01/2023 - 03/2004
10Insulin-Like Growth Factor I (IGF-1)IBA
06/2022 - 09/2009
8Octreotide (Sandostatin)FDA LinkGeneric
06/2020 - 09/2007
7GlucocorticoidsIBA
01/2022 - 11/2004
5pasireotideIBA
06/2020 - 10/2014
5Proteins (Proteins, Gene)FDA Link
06/2012 - 10/2006
4Somatostatin Receptors (Somatostatin Receptor)IBA
08/2023 - 12/2008
4CabergolineFDA LinkGeneric
01/2023 - 11/2012
4aryl hydrocarbon receptor-interacting proteinIBA
01/2023 - 05/2007
4Glucose (Dextrose)FDA LinkGeneric
02/2020 - 07/2016
4Temozolomide (Temodar)FDA LinkGeneric
01/2019 - 10/2010
4Messenger RNA (mRNA)IBA
01/2016 - 07/2003
3LigandsIBA
08/2023 - 01/2020
3Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2023 - 01/2017
3lanreotide (Somatuline)FDA Link
06/2020 - 11/2014
3Biomarkers (Surrogate Marker)IBA
09/2019 - 07/2016
3Dexamethasone (Maxidex)FDA LinkGeneric
08/2015 - 06/2009
3Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric
08/2015 - 12/2004
2Somatotropin Receptors (Growth Hormone Receptor)IBA
08/2023 - 12/2018
2OsilodrostatIBA
01/2023 - 12/2021
2Immunoglobulins (Immunoglobulin)IBA
01/2023 - 06/2016
2Gonadotropin-Releasing Hormone (GnRH)FDA Link
06/2022 - 01/2016
2Vasopressins (Vasopressin)IBA
02/2022 - 12/2004
2Ketoconazole (Nizoral)FDA LinkGeneric
12/2021 - 05/2014
2Protein Isoforms (Isoforms)IBA
11/2021 - 01/2021
2Insulin (Novolin)FDA Link
09/2021 - 01/2020
2Triglycerides (Triacylglycerol)IBA
09/2021 - 12/2017
2Dopamine (Intropin)FDA LinkGeneric
06/2021 - 01/2012
2fluorodopa F 18IBA
02/2020 - 02/2018
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2019 - 06/2018
2SteroidsIBA
06/2018 - 05/2014
2Chromogranin AIBA
02/2018 - 10/2014
2N 30IBA
04/2016 - 07/2010
2GonadotropinsIBA
12/2012 - 07/2003
2Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
08/2012 - 01/2010
2Mifepristone (RU 486)FDA Link
08/2012 - 01/2010
2Alkylating AgentsIBA
06/2012 - 06/2012
2Pro-Opiomelanocortin (Proopiomelanocortin)IBA
10/2006 - 07/2003
1Glucagon-Like Peptide 1 (GLP 1)IBA
03/2024
1Exenatide (Byetta)FDA Link
03/2024
1Glucagon-Like Peptide-1 Receptor AgonistsIBA
03/2024
1Pituitary HormonesIBA
03/2024
1Arginine Vasopressin (Argipressin)IBA
03/2024
1vinyltriethoxysilane (VTES)IBA
01/2024

Therapy/Procedure

28Therapeutics
04/2023 - 02/2002
12Radiotherapy
12/2022 - 08/2005
7Adrenalectomy
03/2021 - 06/2012
2Immunotherapy
05/2023 - 09/2019
2Thyroidectomy
01/2022 - 01/2019
2Immunomodulation
09/2019 - 02/2015
2Drug Therapy (Chemotherapy)
06/2012 - 06/2012